ArticleMedical science monitor : international medical journal of experimental and clinical research2025
Benefits of Sodium-Glucose Cotransporter-2 Inhibitors with Renin-Angiotensin System Blockers in Type-2 Diabetes: A Cohort Analysis.
Ming-Hsien Tsai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.